Relationship Between Thiopurine S-Methyltransferase Genotype/Phenotype and 6-Thioguanine Nucleotide Levels in 316 Patients With Inflammatory Bowel Disease on 6-Thioguanine-Reference-Cited by-同舟云学术

Relationship Between Thiopurine S-Methyltransferase Genotype/Phenotype and 6-Thioguanine Nucleotide Levels in 316 Patients With Inflammatory Bowel Disease on 6-Thioguanine

Published:2021-02-01 Issue:5 Volume:43 Page:617-623
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Bayoumy Ahmed B.,Mulder Chris J. J.,Loganayagam Aathavan,Sanderson Jeremy D.,Anderson Simon,Boekema Paul J.,Derijks Luc J. J.,Ansari Azhar R.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference37 articles.

1. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease;Chande;Cochrane Database Syst Rev.,2015

2. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management;Harbord;J Crohn's Colitis.,2017

3. Finding hidden treasures in old drugs: the challenges and importance of licensing generics;Simsek;Drug Discov Today.,2018

4. Thiopurine therapy in inflammatory bowel disease patients: analyses of two 8-year intercept cohorts;Jharap;Inflamm Bowel Dis.,2010

5. Thiopurine therapy in inflammatory bowel diseases: making new friends should not mean losing old ones;de Boer;Gastroenterology.,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uphill battle: Innovation of thiopurine therapy in global inflammatory bowel disease care;Indian Journal of Gastroenterology;2024-02

2. The Role of Pharmacogenetics in the Therapeutic Response to Thiopurines in the Treatment of Inflammatory Bowel Disease: A Systematic Review;Journal of Clinical Medicine;2023-10-25

3. Implications of Tioguanine Dosing in IBD Patients with a TPMT Deficiency;Metabolites;2023-10-06

4. Implications of tioguanine dosing in IBD patients with a TPMT deficiency;2023-01-23

5. Therapeutic drug monitoring of immunosuppressive drugs in hepatology and gastroenterology;Best Practice & Research Clinical Gastroenterology;2021-10